JAMA Pediatr by Agwu, Allison L. et al.
CD4 Counts of Nonperinatally HIV–Infected Youth and Young 
Adults Presenting for HIV Care Between 2002 and 2010
Allison L. Agwu, MD, ScM, Asha Neptune, MA, MPH, Cindy Voss, MA, Baligh Yehia, MD, 
MPP, MSHP, and Richard Rutstein, MD for the HIV Research Network
Division of Pediatric Infectious Diseases, Department of Pediatrics, Johns Hopkins School of 
Medicine, Baltimore, Maryland (Agwu); Division of Infectious Diseases, Department of Medicine, 
Johns Hopkins School of Medicine, Baltimore, Maryland (Agwu, Voss); Howard University 
College of Medicine, Washington, DC (Neptune); Department of Medicine, Perelman School of 
Medicine, University of Pennsylvania, Philadelphia (Yehia); Division of General Pediatrics, 
Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania (Rutstein)
Human immunodeficiency virus (HIV) incidence is increasing among youth, particularly 
young men who have sex with men and racial/ethnic minorities. Earlier presentation to care, 
a goal of public health initiatives, can limit immune deterioration and HIV transmission. We 
determined if fewer nonperinatally HIV (nPHIV)–infected youth are presenting for care at 
lower CD4 counts.
Methods
This was a retrospective study of nPHIV-infected 12- to 24-year-olds presenting for care at 
HIV Research Network (HIVRN) sites between 2002 and 2010.1 The 13 geographically 
distributed sites that contributed data over the study period all had institutional review board 
approval for the study (from Alameda County Medical Center, Children’s Hospital of 
Philadelphia, Community Health Network, Drexel University, Johns Hopkins University, 
Montefiore Medical Group, Montefiore Medical Center, Oregon Health and Science 
University, Parkland Health and Hospital System, St. Jude’s Children’s Hospital and 
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University of Tennessee, St. Luke’s Roosevelt Hospital Center, Tampa General Health Care, 
University of California, San Diego, and Wayne State University). Eligible patients, who 
provided informed consent (oral or written depending on the rules of the approving 
institutional review board), had at least 1 CD4 value and were antiretroviral therapy naive. 
To assure exclusion of patients who received care previously, we excluded patients whose 
first recorded HIV-1 RNA level was less than the limit of detection of the used assay or less 
than 2.6 log10 HIV-1 RNA copies/mL (n = 174); patients whose first CD4 or HIV-1 RNA 
measurement preceded clinic enrollment by more than 45 days (n = 200); and those with 
incomplete data (n = 2; unable to rule out prior antiretroviral therapy). The primary outcome 
was a presenting CD4 count less than 350 cells/mm3. Multivariate logistic regression 
assessed demographic and clinical factors associated with the outcome. Given the large 
proportion of males, we also conducted a male-only subgroup analysis.
Results
One thousand four hundred ninety-seven nPHIV-infected 12- to 24-year-old youth presented 
to care at HIVRN sites (Table 1). The proportion with a presenting CD4 count less than 350 
cells/mm3 remained between 30% and 45% over the study period (P trend >.05). Black race 
(adjusted odds ratio [AOR], 2.03 [95% CI, 1.31–3.15]), Hispanic ethnicity (AOR, 1.69 [95% 
CI, 1.21–2.34]), male gender (AOR, 1.63 [95% CI, 1.16–2.30]), heterosexual acquisition 
risk (AOR, 1.43 [95% CI, 1.08–1.88]), higher HIV-1 RNA level, and increasing age (AOR, 
1.14 [95% CI, 1.06–1.23]) were independently associated with a greater likelihood of a 
presenting CD4 count less than 350 cells/mm3 (Table 2). These findings remained consistent 
in the male-only subgroup analysis (Table 3).
Discussion
Between 2002 and 2010, there was no overall improvement in presenting CD4 count among 
nPHIV-infected youth at HIVRN sites, contrary to data in adults.2,3 The trend in youth may 
be related to continued risk behaviors in this population related to developmental and 
cognitive stage, in addition to testing and engagement challenges. As in adults, racial/ethnic 
minority status is associated with lower presenting CD4 count among youth, particularly 
young men who have sex with men, a population at the forefront of the youth epidemic. 
While recent data show improvements in racial/ethnic disparities in adults,3 our data 
demonstrate no apparent improvement over the past decade for youth. The gender disparity 
among youth is opposite to that in adults.2,3
Female youth may access health care more frequently than males, in part because of 
reproductive and gynecologic/obstetric needs,4 which may increase opportunities for HIV 
testing and linkage to care. More effective methods to recruit at-risk male youth into early 
testing and linkage to care are needed.
Heterosexual acquisition was also associated with an increased likelihood of presenting with 
a CD4 count less than 350 cells/mm3, highlighting a potential gap in outreach efforts 
because they may engage in high risk behaviors and not perceive that they are at risk and 
thereby test and present for care later.5 Lastly, higher HIV-1 RNA level, which increases 
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risk of progression to AIDS, was associated with a presenting CD4 count less than 350 
cells/mm3. Of concern is that significant proportions of youth, who often continue to engage 
in high-risk behaviors,6 had high HIV-1 RNA levels, increasing HIV transmission risk.
The study has some limitations. Socioeconomic data are not collected by HIVRN, and 
mental health and substance abuse data are incomplete and were not evaluated. A limited 
number of 12- to 16-year-olds, injection drug users, or heterosexual males were in the 
cohort. Last, some patients may have presented for care previously at other sites.
Conclusions
The proportion of nPHIV-infected youth presenting to HIVRN sites with a CD4 count less 
than 350 cells/mm3 remained essentially unchanged between 2002 and 2010. Minority, 
male, and heterosexual youth may warrant innovative strategies to target these populations.
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Table 2
Factors Associated With CD4 Count Less Than 350 Cells/mm3 at Presentation for Care to HIVRN Sites
Factor Univariate OR (95% CI) Multivariatea AOR (95% CI)
Race/ethnicity
 White 1 [Reference] 1.0 [Reference]
 Black 1.22 (1.01–1.48)b 2.03 (1.31–3.15)b
 Hispanic 1.12 (0.97–1.30) 1.69 (1.21–2.34)b
Male 1.60 (1.37–1.86)b 1.63 (1.16–2.30)b
Age at presentation 1.12 (1.07–1.16)b 1.14 (1.06–1.23)b
HIV acquisition risk
 MSM 1 [Reference] 1 [Reference]
 HET 0.91 (0.80–1.03) 1.43 (1.08–1.88)b
 IDU 0.51 (0.32–0.80)b 0.85 (0.41–1.76)
HIV-1 RNA, log10 copies/mL
 2.6–<4.0 1 [Reference] 1 [Reference]
 4.0–<4.7 1.95 (1.45–2.63)b 2.00 (1.54–2.59)b
 4.7–<5.0 3.54 (2.50–5.02)b 3.78 (2.54–5.64)b
 ≥5.0 7.11 (5.61–9.00)b 8.40 (6.82–10.3)b
 Missing 2.58 (1.21–5.50)b 2.50 (1.18–5.28)b
Abbreviations: AOR, adjusted odds ratio; HET, heterosexual; HIV, human immunodeficiency virus; HIVRN, HIV Research Network; IDU, 
injection drug use; MSM, men who have sex with men; OR, odds ratio.
a
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Table 3
Factors Associated With CD4 Count Less Than 350 Cells/mm3 at Presentation for Care to HIVRN Sites: 
Subgroup Analysis of the 1149 Males in the HIVRN Cohort
Factor Univariate OR (95% CI) Multivariatea AOR (95% CI)
Race/ethnicity
 White 1 [Reference] 1 [Reference]
 Black 1.36 (1.08–1.72)b 2.14 (1.25–3.64)b
 Hispanic 1.08 (0.89–1.31) 1.75 (1.18–2.59)b
Age at presentation 1.11 (1.08–1.14)b 1.15 (1.08–1.22)b
HIV acquisition risk
 MSM 1 [Reference] 1 [Reference]
 HET 1.53 (1.20–1.97)b 1.42 (1.04–1.94)b
 IDU 0.58 (0.35–0.95)b 0.77 (0.39–1.51)
HIV-1 RNA, log10 copies/mL
 2.6–<4.0 1 [Reference] 1 [Reference]
 4.0–<4.7 2.00 (1.20–3.32)b 2.08 (1.27–3.41)b
 4.7–<5.0 3.31 (2.24–4.89)b 3.61 (2.38–5.48)b
 ≥5.0 6.39 (4.44–9.21)b 7.63 (5.40–10.8)b
 Missing 2.57 (1.38–4.77)b 2.29 (1.15–4.54)b
Abbreviations: AOR, adjusted odds ratio; HET, heterosexual; HIV, human immunodeficiency virus; HIVRN, HIV Research Network; IDU, 
injection drug use; MSM, men who have sex with men; OR, odds ratio.
a
Subgroup analysis of males: multivariate logistic regression adjusted for year presented to care, race/ethnicity, HIV acquisition risk, age at 
enrollment, viral load, region, and site.
b
Significant.
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